- Zepp Health Corp ZEPP reported a fourth-quarter FY21 revenue decline of 15.8% year-on-year to $260.8 million, missing the consensus of $294.2 million.
- The decrease in Mi band shipments mostly drove the reduction. COVID-19 and the semiconductor crisis during the holiday season affected the self-brand product sales.
- Margin: The gross margin expanded 30 bps to 19.3%.
- Adjusted income per ADS of $0.12 missed the consensus of $0.37.
- Zepp held $230.4 million in cash and equivalents.
- Drivers: Total units shipped fell 37.6% Y/Y to 8.3 million. The unit shipments of Amazfit and Zepp-branded products increased 14.3% Y/Y.
- Unit shipment for Xiaomi wearable products fell 47.3% Y/Y.
- Dividend: The board approved a special cash dividend of $0.1 per ADS.
- Price Action: ZEPP shares traded higher by 0.32% at $3.13 in the premarket on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in